The afferent pathway of the late response (R2 component) of the blink reflex in response to transcutaneous electrical stimulation of the facial nerve over the stylomastoid foramen remains uncertain. The two major hypotheses regarding the afferent pathway of R2 are that it may consist of either the trigemino-facial or the facio-facial reflex. This study was performed to determine the afferent pathway of R2. Ninety-one patients with acute unilateral peripheral facial palsy and 21 controls were studied. The degree of facial nerve damage was classified into three groups: mild, moderate, and severe according to their electroneurographic value. In each group, the appearance rate, latency, and area under the curve of contralateral R2 elicited by electrical stimulation of the injured facial nerve over the stylomastoid foramen were measured and compared with those of controls. The contralateral R2 parameters did not differ between the patient groups and the controls. The results indicate that the afferent pathway of R2 is mediated not only through the facial nerve. We conclude that the auriculotemporal nerve (V3) and the great auricular nerve (C2, C3) may also contribute to the afferent pathway of R2.

Keywords:
Blink reflex, Pathway, Facial nerve, Trigeminal nerve
This content is only available via PDF.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.